IDEMIA
14.12.2020 10:32:12 CET | Business Wire | Press release
IDEMIA:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005279/en/
Security and convenience at the heart of the Icelandic project
By 2022, new EU-EES regulations will require that biometric data, including face and fingerprints, of Third Country Nationals (TCNs) be captured and identified at the Schengen Area’s external borders. This will affect border check processes for all Schengen Member States.
With 20%-a-year air traffic growth (prior to COVID-19), Iceland planned to implement a program to manage increased passenger flows primarily in Iceland’s main international airport Keflavik, where 95% of the country’s largely non EU arriving and exiting passengers pass, and also in the country’s 30 seaports defined as external sea border crossing points. The new border management systems and equipment will also contribute to inland control within the Schengen Area.
Iceland, innovation partner in border management
IDEMIA will leverage its best-in-class biometric and border control expertise to uphold and upgrade Iceland’s border security. Meanwhile, this cutting-edge technology will contribute to more secured external borders and optimize the passenger flow by the use of the newest technology in border management.
This new border management system, based on IDEMIA’s Augmented Borders™ solution, will be compliant with EU-EES regulations. IDEMIA will also equip Icelandic border crossing points with its TravelKiosk™ EU-EES, the latest generation of user-centric multi-biometric border self-service kiosks . Also including automated TraveLane™ eGates, the entire system will boost throughput and convenience of passengers as they go through border controls. Lastly, to complete this end-to-end solution, IDEMIA will ensure that operator-manned counters, mobile solutions and tracking systems are set up to fit the requirements of the Icelandic Police with a view to shortening response times and improving coordination.
“The National Commissioner of the Icelandic Police, the Metropolitan Police and Sudurnes District police have from early 2019 been working on the implementation of EES in Iceland in close cooperation with Isavia. The procurement procedure started in September 2019 and today we have reached an important milestone by selecting IDEMIA as the supplier and future partner for the implementation of EES in Iceland. The police and Isavia place a high expectation to the collaboration with IDEMIA in the development of solutions that will improve border security and the traveler experience,” said Jón Pétur Jónsson , Chief Superintendent, at the National Commissioner of the Icelandic Police.
“ Isavia is truly excited about this co-operation with IDEMIA and the Icelandic Police. This is an important step in improving the performance and customer experience of the convenient and easy hub connection between Europe and North America, ” says Guðmundur Daði Rúnarsson , Chief Commercial and Airport Development Officer at Isavia. “ The Entry Exit system will affect all airports with traffic crossing external borders. Isavia is confident that implementing IDEMIA’s self service solutions in co-operation with the border police, will result in a more secure and efficient border crossing point, giving Keflavik the potential to grow even further in its Hub operation. ”
“IDEMIA is proud to accompany Iceland as one of the first countries of the Schengen Area to transform its border control system to comply with the European Entry/Exit System. We are determined to provide a comprehensive set of multi-biometric solutions that will give the assurance of a future-proof program, making Iceland our innovation partner in the implementation of the EU-EES. Our advanced border management solutions, based on a 40-year relationship with governments, will offer a better user experience by interactively adapting the border process per traveler category, while ensuring maximum security,” said Philippe Barreau , Executive Vice President for Public Security & Identity activities at IDEMIA.
As world leader in government identity and police biometric systems, IDEMIA brings to the table its cutting-edge technology and know-how so that personal identity is checked in the most secure way.
Recently, IDEMIA, in partnership with Sopra Steria, was selected to roll out the shared Biometric Matching System - the new European automated multi-biometric identification system for foreign nationals hosted by EU agency eu-LISA. Having partnered with EU institutions for many years and installed border control systems in more than 23 countries, IDEMIA’s comprehensive package meets the complex requirements of border control authorities, topped off by state-of-the-art technology.
About IDEMIA
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.
For more information, visit www.idemia.com or follow @IDEMIAGroup on Twitter
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005279/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
